Your browser doesn't support javascript.
loading
Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19.
Peidli, Stefan; Nouailles, Geraldine; Wyler, Emanuel; Adler, Julia M; Kunder, Sandra; Voß, Anne; Kazmierski, Julia; Pott, Fabian; Pennitz, Peter; Postmus, Dylan; Teixeira Alves, Luiz Gustavo; Goffinet, Christine; Gruber, Achim D; Blüthgen, Nils; Witzenrath, Martin; Trimpert, Jakob; Landthaler, Markus; Praktiknjo, Samantha D.
Afiliación
  • Peidli S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Berlin, Germany; Institute for Biology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Nouailles G; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.
  • Wyler E; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Adler JM; Institut für Virologie, Freie Universität Berlin, Berlin, Germany.
  • Kunder S; Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Voß A; Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Kazmierski J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Pott F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Pennitz P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.
  • Postmus D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Teixeira Alves LG; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Goffinet C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Gruber AD; Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Blüthgen N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Berlin, Germany; Institute for Biology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Witzenrath M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany; German Center for Lung Research (DZL), Berlin, Germany.
  • Trimpert J; Institut für Virologie, Freie Universität Berlin, Berlin, Germany; Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
  • Landthaler M; Institute for Biology, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Praktiknjo SD; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: samantha.praktiknjo@bih-charite.de.
Cell Rep ; 43(6): 114328, 2024 Jun 25.
Article en En | MEDLINE | ID: mdl-38861386
ABSTRACT
A key issue for research on COVID-19 pathogenesis is the lack of biopsies from patients and of samples at the onset of infection. To overcome these hurdles, hamsters were shown to be useful models for studying this disease. Here, we further leverage the model to molecularly survey the disease progression from time-resolved single-cell RNA sequencing data collected from healthy and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected Syrian and Roborovski hamster lungs. We compare our data to human COVID-19 studies, including bronchoalveolar lavage, nasal swab, and postmortem lung tissue, and identify a shared axis of inflammation dominated by macrophages, neutrophils, and endothelial cells, which we show to be transient in Syrian and terminal in Roborovski hamsters. Our data suggest that, following SARS-CoV-2 infection, commitment to a type 1- or type 3-biased immunity determines moderate versus severe COVID-19 outcomes, respectively.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Endoteliales / Análisis de la Célula Individual / SARS-CoV-2 / COVID-19 / Pulmón / Neutrófilos Límite: Animals / Humans / Male Idioma: En Revista: Cell Rep Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Endoteliales / Análisis de la Célula Individual / SARS-CoV-2 / COVID-19 / Pulmón / Neutrófilos Límite: Animals / Humans / Male Idioma: En Revista: Cell Rep Año: 2024 Tipo del documento: Article País de afiliación: Alemania